Column Capital Advisors’s Guardant Health GH Stock Holding History

Column Capital Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200	Closed	-$11K	–	847
2022 Q3	$11K	Hold	200	–	–	﹤0.01%	455
2022 Q2	$8K	Hold	200	–	–	﹤0.01%	506
2022 Q1	$13K	Hold	200	–	–	﹤0.01%	462
2021 Q4	$20K	Hold	200	–	–	﹤0.01%	411
2021 Q3	$25K	Hold	200	–	–	0.01%	361
2021 Q2	$25K	Hold	200	–	–	0.01%	359
2021 Q1	$31K	Hold	200	–	–	0.01%	331
2020 Q4	$26K	Hold	200	–	–	0.01%	358
2020 Q3	$22K	Hold	200	–	–	0.01%	352
2020 Q2	$16K	Hold	200	–	–	0.01%	407
2020 Q1	$14K	Hold	200	–	–	0.01%	355
2019 Q4	$15K	Buy	+200	New	+$14.4K	0.01%	400

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Column Capital Advisors's GH Position: Q4 2022 in Review

Column Capital Advisors sold out of Guardant Health (GH) in Q4 2022, closing a stake of 200 shares — an estimated $11K sold.

Column Capital Advisors first reported a position in GH in Q4 2019 and held it in 12 quarters. The position peaked at $31K in Q1 2021. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

Column Capital Advisors reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
Column Capital Advisors sold 200 Guardant Health shares in Q4 2022, an estimated $11K.
Column Capital Advisors first reported a position in Guardant Health in Q4 2019 and held it in 12 quarters.
Column Capital Advisors's Guardant Health position peaked at $31K in Q1 2021.
290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Column Capital Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.